<html><body style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; "><div style="margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; "><i>Leishmania</i> Genomes </div><div style="margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; ">Leishmaniasis, a parasitic disease caused by various species of the protozoan genus <i>Leishmania</i>, is an important health problem in much of the tropical parts of the world, causing disfiguring cutaneous lesions and more serious complications. NCBI (<a href="http://www.ncbi.nlm.nih.gov/">http://www.ncbi.nlm.nih.gov/</a>) now has the genomes of two of the human pathogenic species of <i>Leishmania (L. braziliensis </i>and<i> L. infantum)</i>. Both genomes will be important in further understanding the biology of these parasites and will help in developing new strategies to combat this disease. The braziliensis and infantum genomes are comprised of completely annotated chromosome records with associated genes and model transcripts. The braziliensis genome was submitted by the Wellcome Trust Sanger Institute and has 31.4 Megabases comprising the 35 chromosomes with 8,129 annotated genes and gene models. The infantum genome submitted by a consortium that included The Wellcome Trust Sanger Institute, Imperial College, and University of Glasgow has 32.1 Megabases comprising the 36 chromosomes with 8,186 annotated genes and gene models. For the <i>Leishmania</i> genomes, the contig, gene, and transcript maps are available within Map Viewer (<a href="http://www.ncbi.nlm.nih.gov/projects/mapview/map_search.cgi?taxid=5664">http://www.ncbi.nlm.nih.gov/projects/mapview/map_search.cgi?taxid=5664</a>). </div></body></html>